• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人外周静脉置入中心静脉导管与中心静脉导管相关血流感染风险的系统评价和荟萃分析。

The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.

机构信息

Patient Safety Enhancement Program, Hospital Outcomes Program of Excellence and Center for Clinical Management Research, Ann Arbor Veterans Affairs Medical Center and University of Michigan School of Medicine, Ann Arbor, Michigan, USA.

出版信息

Infect Control Hosp Epidemiol. 2013 Sep;34(9):908-18. doi: 10.1086/671737. Epub 2013 Jul 26.

DOI:10.1086/671737
PMID:23917904
Abstract

BACKGROUND

Peripherally inserted central catheters (PICCs) are associated with central line-associated bloodstream infection (CLABSI). The magnitude of this risk relative to central venous catheters (CVCs) is unknown.

OBJECTIVE

To compare risk of CLABSI between PICCs and CVCs.

METHODS

MEDLINE, CinAHL, Scopus, EmBASE, and Cochrane CENTRAL were searched. Full-text studies comparing the risk of CLABSI between PICCs and CVCs were included. Studies involving adults 18 years of age or older who underwent insertion of a PICC or a CVC and reported CLABSI were included in our analysis. Studies were evaluated using the Downs and Black scale for risk of bias. Random effects meta-analyses were used to generate summary estimates of CLABSI risk in patients with PICCs versus CVCs.

RESULTS

Of 1,185 studies identified, 23 studies involving 57,250 patients met eligibility criteria. Twenty of 23 eligible studies reported the total number of CLABSI episodes in patients with PICCs and CVCs. Pooled meta-analyses of these studies revealed that PICCs were associated with a lower risk of CLABSI than were CVCs (relative risk [RR], 0.62; 95% confidence interval [CI], 0.40-0.94). Statistical heterogeneity prompted subgroup analysis, which demonstrated that CLABSI reduction was greatest in outpatients (RR [95% CI], 0.22 [0.18-0.27]) compared with hospitalized patients who received PICCs (RR [95% CI], 0.73 [0.54-0.98]). Thirteen of the included 23 studies reported CLABSI per catheter-day. Within these studies, PICC-related CLABSI occurred as frequently as CLABSI from CVCs (incidence rate ratio [95% CI], 0.91 [0.46-1.79]).

LIMITATIONS

Only 1 randomized trial met inclusion criteria. CLABSI definition and infection prevention strategies were variably reported. Few studies reported infections by catheter-days.

CONCLUSIONS

Although PICCs are associated with a lower risk of CLABSI than CVCs in outpatients, hospitalized patients may be just as likely to experience CLABSI with PICCs as with CVCs. Consideration of risks and benefits before PICC use in inpatient settings is warranted.

摘要

背景

外周置入中心静脉导管(PICC)与中心静脉相关血流感染(CLABSI)有关。其与中心静脉导管(CVC)相关的风险程度尚不清楚。

目的

比较 PICC 和 CVC 发生 CLABSI 的风险。

方法

检索 MEDLINE、CinAHL、Scopus、EmBASE 和 Cochrane CENTRAL。纳入比较 PICC 和 CVC 发生 CLABSI 风险的全文研究。纳入分析的研究对象为接受 PICC 或 CVC 置管且报告 CLABSI 的年龄 18 岁及以上的成年人。使用 Downs 和 Black 量表评估研究的偏倚风险。采用随机效应荟萃分析生成 PICC 与 CVC 患者 CLABSI 风险的综合估计值。

结果

在 1185 项研究中,有 23 项研究纳入 57250 名患者符合入选标准。23 项合格研究中有 20 项报告了 PICC 和 CVC 患者 CLABSI 发作的总例数。对这些研究的汇总分析显示,与 CVC 相比,PICC 发生 CLABSI 的风险较低(相对风险 [RR],0.62;95%置信区间 [CI],0.40-0.94)。鉴于存在统计学异质性,故进行了亚组分析,结果显示门诊患者 CLABSI 减少幅度最大(RR [95%CI],0.22 [0.18-0.27]),而接受 PICC 的住院患者则较小(RR [95%CI],0.73 [0.54-0.98])。纳入的 23 项研究中有 13 项报告了每根导管的 CLABSI 发生率。在这些研究中,PICC 相关性 CLABSI 的发生率与 CVC 相关性 CLABSI 相同(发病率比 [95%CI],0.91 [0.46-1.79])。

局限性

仅 1 项随机试验符合纳入标准。CLABSI 定义和感染预防策略的报告存在差异。很少有研究报告以导管日计算的感染。

结论

虽然与 CVC 相比,PICC 在外周静脉置管患者中与 CLABSI 的相关性较低,但住院患者接受 PICC 治疗时发生 CLABSI 的可能性与 CVC 相当。在住院环境中使用 PICC 前应考虑其风险和获益。

相似文献

1
The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.成人外周静脉置入中心静脉导管与中心静脉导管相关血流感染风险的系统评价和荟萃分析。
Infect Control Hosp Epidemiol. 2013 Sep;34(9):908-18. doi: 10.1086/671737. Epub 2013 Jul 26.
2
Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.与经外周静脉置入中心静脉导管相关的静脉血栓栓塞风险:系统评价和荟萃分析。
Lancet. 2013 Jul 27;382(9889):311-25. doi: 10.1016/S0140-6736(13)60592-9. Epub 2013 May 20.
3
Peripherally inserted central catheter design and material for reducing catheter failure and complications.用于减少导管故障和并发症的外周静脉穿刺中心静脉导管的设计与材料
Cochrane Database Syst Rev. 2024 Jun 28;6(6):CD013366. doi: 10.1002/14651858.CD013366.pub2.
4
Dressings and securement devices for central venous catheters (CVC).中心静脉导管(CVC)的敷料和固定装置。
Cochrane Database Syst Rev. 2015 Sep 10;2015(9):CD010367. doi: 10.1002/14651858.CD010367.pub2.
5
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.用于降低成人中心静脉导管相关感染的导管浸渍、涂层或粘结
Cochrane Database Syst Rev. 2016 Mar 16;3(3):CD007878. doi: 10.1002/14651858.CD007878.pub3.
6
Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.预防抗生素用于预防与成人和儿童癌症治疗期间长期使用中心静脉导管相关的革兰氏阳性感染。
Cochrane Database Syst Rev. 2021 Oct 7;10(10):CD003295. doi: 10.1002/14651858.CD003295.pub4.
7
Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis.抗菌外周静脉穿刺中心静脉导管与中心静脉导管相关血流感染的减少有关吗?一项系统评价和荟萃分析。
Am J Infect Control. 2017 Feb 1;45(2):108-114. doi: 10.1016/j.ajic.2016.07.021. Epub 2016 Oct 27.
8
Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.用于预防肿瘤患者长期中心静脉导管相关革兰氏阳性菌感染的预防性抗生素。
Cochrane Database Syst Rev. 2013 Nov 25;2013(11):CD003295. doi: 10.1002/14651858.CD003295.pub3.
9
Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters.用于预防新生儿中心静脉导管相关感染的抗菌敷料。
Cochrane Database Syst Rev. 2016 Mar 23;3(3):CD011082. doi: 10.1002/14651858.CD011082.pub2.
10
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.用于降低成人中心静脉导管相关感染的导管浸渍、涂层或粘结
Cochrane Database Syst Rev. 2013 Jun 6(6):CD007878. doi: 10.1002/14651858.CD007878.pub2.

引用本文的文献

1
Economic analysis: PICC versus short catheter for prolonged home antibiotic therapy.经济分析:经外周静脉穿刺中心静脉置管与短导管用于长期家庭抗生素治疗的比较
Rev Cuid. 2025 May 1;16(2):e4124. doi: 10.15649/cuidarte.4124. eCollection 2025 May-Aug.
2
Peripherally inserted central catheters versus implanted port catheters in patients with breast cancer: a analysis of the PICCPORT randomised controlled trial.乳腺癌患者外周静脉穿刺中心静脉导管与植入式端口导管的比较:PICCPORT随机对照试验分析
BJA Open. 2025 Feb 4;13:100377. doi: 10.1016/j.bjao.2025.100377. eCollection 2025 Mar.
3
Midodrine for the early liberation from vasopressor support in the ICU (LIBERATE): a feasibility study.
米多君用于重症监护病房中早期停用血管升压药支持治疗(LIBERATE):一项可行性研究。
Pilot Feasibility Stud. 2024 Dec 4;10(1):147. doi: 10.1186/s40814-024-01577-2.
4
Comparison of complication types in patients receiving vesicant intravenous antimicrobials or vasopressors via midlines and peripherally inserted central catheters.通过中线导管和外周静脉穿刺中心静脉导管接受刺激性静脉用抗菌药物或血管加压药的患者并发症类型的比较。
Antimicrob Steward Healthc Epidemiol. 2024 Sep 5;4(1):e116. doi: 10.1017/ash.2024.363. eCollection 2024.
5
Effectiveness of a nurse-led peripherally inserted central catheter service: A retrospective cohort study.护士主导的经外周静脉穿刺中心静脉置管服务的有效性:一项回顾性队列研究。
J Vasc Access. 2025 Jul;26(4):1257-1264. doi: 10.1177/11297298241263886. Epub 2024 Aug 11.
6
Vascular access specialist teams versus standard practice for catheter insertion and prevention of failure: a systematic review.血管通路专家团队与导管插入和预防失败的标准实践:系统评价。
BMJ Open. 2024 Jul 5;14(7):e082631. doi: 10.1136/bmjopen-2023-082631.
7
Peripherally inserted central catheter design and material for reducing catheter failure and complications.用于减少导管故障和并发症的外周静脉穿刺中心静脉导管的设计与材料
Cochrane Database Syst Rev. 2024 Jun 28;6(6):CD013366. doi: 10.1002/14651858.CD013366.pub2.
8
Antibiofilm Strategies in Neonatal and Pediatric Infections.新生儿及儿科感染中的抗生物膜策略
Antibiotics (Basel). 2024 May 30;13(6):509. doi: 10.3390/antibiotics13060509.
9
Thrombosis and infections associated with PICC in onco-hematological patients, what is their relevance?肿瘤血液病患者经外周中心静脉置管(PICC)相关的血栓和感染,它们有何关联?
Clin Transl Oncol. 2024 Dec;26(12):3226-3235. doi: 10.1007/s12094-024-03548-8. Epub 2024 Jun 12.
10
Clinical characteristics and risk factors for right-sided infective endocarditis in Korea: a 12-year retrospective cohort study.韩国右心感染性心内膜炎的临床特征和危险因素:一项 12 年回顾性队列研究。
Sci Rep. 2024 May 7;14(1):10466. doi: 10.1038/s41598-024-60638-x.